This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract, valued at $810,091.80, was awarded by the Veterans Health Administration (VHA) of the Department of Veterans Affairs (VA) under the VA's Veterans Integrated Service Network (VISN) 8. The contract is a BPA (Blanket Purchase Agreement) call against Biofire's General Services Administration (GSA) Federal Supply...
This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, valued at $116,104.53, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for "MOLECULAR PATHOGEN DETECTION" services. It was awarded as a Blanket Purchase Agreement (BPA) call, a type of Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, against Biofire's existing General...
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for the provision of molecular pathogen detection services. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents and tests. The $430,808.73 ceiling value contract has a firm fixed price pricing type and was awarded by the...
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for the provision of MOLECULAR PATHOGEN DETECTION services. The $977,947.90 Firm Fixed Price contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its various Veterans Integrated Service Networks. The contract is a call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for...
This is a federal contract award to Biofire Diagnostics LLC, a biotechnology company that specializes in syndromic infectious disease testing. The contract, awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), is for molecular pathogen detection services. The contract has a ceiling value of $513,156.00 and a period of performance through September 30, 2024. The contract was awarded against Biofire's existing General Services Administration (GSA) Federal...
This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The award, valued at $1,598,542.00, is for molecular pathogen detection products and services. The contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its Veterans Integrated Service Network (VISN) 8. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration...
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for a Blanket Purchase Agreement (BPA) call under their existing General Services Administration (GSA) Federal Supply Schedule 65-VII contract for in vitro diagnostics, reagents, and tests. The contract is with the Veterans Health Administration (VHA) within the Department of Veterans Affairs and has a ceiling value of $171,925.20. It is for the provision of...
This federal contract award to Biofire Diagnostics LLC, a for-profit foreign-owned biotech company, is for "MOLECULAR PATHOGEN DETECTION" services. The contract is a Blanket Purchase Agreement (BPA) Call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has a firm fixed price and a total ceiling value of $1,310,556.75. The award was made by the Department of Veterans Affairs (VA) Veterans...
This is a federal contract award to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The contract, valued at $6,877,509.36, is for BIOFIRE TESTING PANELS and was awarded by the Veterans Health Administration (VHA), which is part of the U.S. Department of Veterans Affairs (VA). The contract is a Delivery Order against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and...
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's own General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The award, valued at $171,925.20, is for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to procure...